Contact ~ editorial only
Contact TB-500 Store
For editorial questions, corrections, and source suggestions on the TB-500 digest. This is an editorial inbox, not a clinical or commercial one.
What to write about
Use the form below to reach the editorial team behind this TB-500 digest. We welcome corrections, questions about how a study was summarized, and suggestions for peer-reviewed sources we should add. If you believe a citation is wrong or a finding is mischaracterized — particularly where the fragment and full-length thymosin beta-4 might have been conflated — tell us and point us to the source.
What we cannot help with: medical advice, dosing, where to obtain any substance, or clinical consultation. We are an editorial publisher. We do not employ clinicians, we do not sell or dispense anything, and we cannot advise on personal use. Questions of that kind are outside what this project does and outside what it is able to answer.
How we handle messages
Editorial and correction messages are read and, where a change to the digest is warranted, acted on against the cited source. We do not collect personal health information, and we ask that you not send any. For the regulatory picture that governs access to compounds like this one, the TB-500 legal status page is the most complete answer we can offer, and it is general information rather than medical or legal advice.